Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioxcel Therapeutics Inc.

2.73
+0.03001.11%
Post-market: 2.760.0300+1.10%19:59 EST
Volume:10.12M
Turnover:31.70M
Market Cap:8.47M
PE:-0.09
High:3.36
Open:3.18
Low:2.73
Close:2.70
Loading ...

BioXcel announces common stock and warrants offering, no amount given

seekingalpha
·
22 Nov 2024

BRIEF-Bioxcel Therapeutics - As Of Nov 18, 431 Patent Has Been Accepted For Listing In FDA Approved Drug Products With Therapeutic Equivalence Evaluations

Reuters
·
22 Nov 2024

BRIEF-Bioxcel Therapeutics Announces Proposed Public Offering

Reuters
·
22 Nov 2024

BioXcel Therapeutics Announces Proposed Public Offering

THOMSON REUTERS
·
22 Nov 2024

BioXcel Therapeutics- as of Nov 18, ‘431 Patent Has Been Accepted for Listing in FDA Approved Drug Products With Therapeutic Equivalence Evaluations

THOMSON REUTERS
·
22 Nov 2024

Bank of America Securities Reaffirms Their Buy Rating on Bioxcel Therapeutics (BTAI)

TIPRANKS
·
15 Nov 2024

BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights: Strategic Trials and ...

GuruFocus.com
·
15 Nov 2024

Q3 2024 BioXcel Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
15 Nov 2024

BioXcel Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
15 Nov 2024

BioXcel Therapeutics, Inc. (BTAI) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
14 Nov 2024

BioXcel Therapeutics Q3 Basic EPS USD -0.32 VS. Ibes Estimate USD -0.54

THOMSON REUTERS
·
14 Nov 2024

BioXcel Therapeutics Q3 Operating Expenses USD 15.507 Million

THOMSON REUTERS
·
14 Nov 2024

BioXcel Therapeutics Q3 Revenue USD 214 Thousand VS. Ibes Estimate USD 1.31 Million

THOMSON REUTERS
·
14 Nov 2024

BioXcel Therapeutics Advances Pivotal Phase 3 Trials of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders, Schizophrenia, and Alzheimer’s Dementia

GlobeNewswire
·
12 Nov 2024

Will BioXcel Therapeutics, Inc. (BTAI) Report Negative Q3 Earnings? What You Should Know

Zacks
·
05 Nov 2024

BioXcel announces defense grant to UNC to fund study for treating acute stress disorder

seekingalpha
·
15 Oct 2024